EMEA-000798-PIP01-09-M03

Table of contents

Key facts

Active substance
ponesimod
Therapeutic area
  • Neurology
  • Other
Decision number
P/0066/2021
PIP number
EMEA-000798-PIP01-09-M03
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of multiple sclerosis
Route(s) of administration
Oral use
Contact for public enquiries
Janssen-Cilag International NV

Tel. + 32 1460 2111
E-mail: contact@janssen-emea.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating